Search

Your search keyword '"Sautto GA"' showing total 56 results

Search Constraints

Start Over You searched for: Author "Sautto GA" Remove constraint Author: "Sautto GA"
56 results on '"Sautto GA"'

Search Results

3. SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity

4. Next Generation Vaccines for Infectious Diseases

5. Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?

6. Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections

7. HCV E2 core structures and mAbs: something is still missing

8. Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome

9. Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein

10. A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments

11. Discovery and characterization of a pan-betacoronavirus S2-binding antibody.

12. Isolation and characterization of IgG3 glycan-targeting antibodies with exceptional cross-reactivity for diverse viral families.

13. Respiratory viruses: Preventive and therapeutic approaches to diverse pathogens.

14. Multiplexed Antibody Sequencing and Profiling of the Human Hemagglutinin-specific Memory B Cell Response following Influenza Vaccination.

15. Structural basis for the broad antigenicity of the computationally optimized influenza hemagglutinin X6.

16. Exploring T-Cell Immunity to Hepatitis C Virus: Insights from Different Vaccine and Antigen Presentation Strategies.

17. Prior SARS-CoV-2 Infection Enhances Initial mRNA Vaccine Response with a Lower Impact on Long-Term Immunity.

18. Structural insights into the broad protection against H1 influenza viruses by a computationally optimized hemagglutinin vaccine.

19. Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor.

20. Kinetic of the Antibody Response Following AddaVax-Adjuvanted Immunization with Recombinant Influenza Antigens.

21. Template-Assisted De Novo Sequencing of SARS-CoV-2 and Influenza Monoclonal Antibodies by Mass Spectrometry.

22. The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza H1 Hemagglutinin Vaccines.

23. The Effect of Waning on Antibody Levels and Memory B Cell Recall following SARS-CoV-2 Infection or Vaccination.

24. New Insights into Immune-Based Diagnosis, Therapy and Prophylaxis for Infectious Diseases 2020.

25. A Competitive Hemagglutination Inhibition Assay for Dissecting Functional Antibody Activity against Influenza Virus.

26. Impaired memory B-cell recall responses in the elderly following recurrent influenza vaccination.

27. Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays.

28. Dual oxidase 1 promotes antiviral innate immunity.

29. An H1N1 Computationally Optimized Broadly Reactive Antigen Elicits a Neutralizing Antibody Response against an Emerging Human-Infecting Eurasian Avian-Like Swine Influenza Virus.

30. Feline Morbillivirus Infection in Domestic Cats: What Have We Learned So Far?

31. Convergent antibody evolution and clonotype expansion following influenza virus vaccination.

32. The Answer Lies in the Energy: How Simple Atomistic Molecular Dynamics Simulations May Hold the Key to Epitope Prediction on the Fully Glycosylated SARS-CoV-2 Spike Protein.

33. High-Yield Expression and Purification of Recombinant Influenza Virus Proteins from Stably-Transfected Mammalian Cell Lines.

35. IgA Responses Following Recurrent Influenza Virus Vaccination.

36. An Influenza Virus Hemagglutinin Computationally Optimized Broadly Reactive Antigen Elicits Antibodies Endowed with Group 1 Heterosubtypic Breadth against Swine Influenza Viruses.

37. Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination.

38. A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin.

39. Hemagglutinin consensus-based prophylactic approaches to overcome influenza virus diversity.

40. Next Generation Vaccines for Infectious Diseases.

41. Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines.

42. Elicitation of Broadly Protective Antibodies following Infection with Influenza Viruses Expressing H1N1 Computationally Optimized Broadly Reactive Hemagglutinin Antigens.

43. Towards a universal influenza vaccine: different approaches for one goal.

44. Infection of Ferrets with Influenza Virus Elicits a Light Chain-Biased Antibody Response against Hemagglutinin.

45. Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge.

46. A Biologically-validated HCV E1E2 Heterodimer Structural Model.

49. Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.

Catalog

Books, media, physical & digital resources